The SuperNova Elite newsletter is all about finding action ready stocks that are trading under $5 per share that can generate solid swing trades and momentum trades for our members. For more details about our program please click here
If you are serious about making money off these swing trades and, for a full report on other hot moving penny and small cap stocks please click here.
KWK – coming off a $3.50 base has resistance at $4.18 and $4.31 ahead and I think both are realistic targets considering the last run went from $3 to $5.80 range. Stop loss at $3.50 imo
Quicksilver Resources Inc., an independent oil and gas company, engages in the acquisition, exploration, development, and production of onshore oil and gas in North America. The company focuses primarily on unconventional reservoirs, such as fractured shales, coal beds, and tight sands. It owns producing oil and natural gas properties principally in Texas, Colorado, Wyoming, and Montana, as well as in Alberta and British Columbia. The company primarily holds interests in assets covering an area of approximately 140,000 net acres located in the Barnett Shale, Fort Worth basin, north Texas; exploratory licenses covering an area of approximately 130,000 net acres located in the Horn River basin of northeast British Columbia; and assets covering an area of approximately 36,929 net undeveloped acres located in the Horseshoe Canyon, southern and central Alberta. As of December 31, 2011, it had total proved reserves of approximately 2.8 trillion cubic feet of natural gas equivalents.
MILL – Solid move off the 20 and 50 MA line break here. Not as much potential as KWK but could see $4.85 in the short term. Heavily shorted stock so if it gets legs, it could move well. Stop at $4.15
Miller Energy Resources, Inc., an independent exploration and production company, engages in the exploration, development, and production of oil and natural gas wells in the Appalachian region of eastern Tennessee and in southcentral Alaska. As of April 30, 2012, the company owned approximately 105,713 gross acres of leasehold interests; the exploration license rights to an additional 534,383 acres; and interests in 10 crude oil and 5 natural gas wells in Cook Inlet and Susitna Basins. It also owned approximately 49,260 gross acres of leasehold interests with 183 producing oil wells, as well as owned interests in 181 producing gas wells in Appalachian region. The company was formerly known as Miller Petroleum, Inc. and changed its name to Miller Energy Resources, Inc. in April 2011.
EXEL another beaten down stock that looks like its showing signs of life. Solid base at $4.15 to $4.20 with resistance at $4.62 and then $5.06 ahead.
Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer. Its focuses on developing cabozantinib product candidate that inhibits MET, VEGFR2, and RET proteins, which are key drivers of tumor growth, vascularization, and/or metastasis. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, melanoma, breast cancer, non-small cell lung cancer, hepatocellular cancer, renal cell carcinoma, and thyroid cancer. In addition, Exelixis, Inc. is involved in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies comprising Bristol-Myers Squibb Company; Sanofi; Genentech, Inc.; GlaxoSmithKline; Merck; and Daiichi Sankyo Company Limited. Its products under development through collaborations primarily include XL475 compound; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147 and XL765 PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000.
JASO – a dark horse here but stocks like JKS (a bit higher price with good potential are moving so maybe JASO will follow) has resistance at $1.14 and $1.21 ahead. Support at $.98 and $.97 so I don’t think this is a big “risk” play.
JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the development, production, marketing, and sale of photovoltaic (PV) solar cells and solar power products that converts sunlight into electricity worldwide. The company?s principal products include monocrystalline and multicrystalline solar cells, as well as various solar modules. It also provides monocrystalline and multicrystalline silicon wafers; solar product processing services; and engineering, procurement, and construction services for solar power projects. The company sells its products primarily under the JA Solar brand name, as well as produces original equipment for manufacturers or customers under their brand names. JA Solar Holdings Co., Ltd. sells its solar cell and module products to module manufacturers, system integrators, project developers, and distributors in Germany, Italy, Spain, France, Bulgaria, the United States, Hong Kong, Japan, India, South Korea, and the People?s Republic of China.
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- See today’s top stock picks and market analysis
- Want more? Check out the message board buzz for these stocks
- See what newsletters are recommending these stock picks
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
- This newsletter has been helping traders make a killing on these stocks. Click here for a 25% discount offer.
BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.
Beacon Equity Group Disclaimer
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.